| Year |
Citation |
Score |
| 2017 |
Tong Z, Chatterjee D, Deng D, Veeranki O, Mejia A, Ajani JA, Hofstetter W, Lin S, Guha S, Kopetz S, Krishnan S, Maru D. Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma. Oncotarget. PMID 28404924 DOI: 10.18632/Oncotarget.15645 |
0.436 |
|
| 2012 |
Kunnumakkara AB, Sung B, Ravindran J, Diagaradjane P, Deorukhkar A, Dey S, Koca C, Tong Z, Gelovani JG, Guha S, Krishnan S, Aggarwal BB. Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets International Journal of Cancer. 131: E292-E303. PMID 21935918 DOI: 10.1002/Ijc.26442 |
0.322 |
|
| 2011 |
Tong Z, Chakraborty S, Sung B, Koolwal P, Kaur S, Aggarwal BB, Mani SA, Bresalier RS, Batra SK, Guha S. Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells. Cancer. 117: 2408-18. PMID 24048788 DOI: 10.1002/Cncr.25803 |
0.311 |
|
| 2011 |
Ochi N, Tanasanvimon S, Matsuo Y, Tong Z, Sung B, Aggarwal BB, Sinnett-Smith J, Rozengurt E, Guha S. Protein kinase D1 promotes anchorage-independent growth, invasion, and angiogenesis by human pancreatic cancer cells. Journal of Cellular Physiology. 226: 1074-81. PMID 20857418 DOI: 10.1002/Jcp.22421 |
0.48 |
|
| 2010 |
Kunnumakkara AB, Sung B, Ravindran J, Diagaradjane P, Deorukhkar A, Dey S, Koca C, Yadav VR, Tong Z, Gelovani JG, Guha S, Krishnan S, Aggarwal BB. γ-Tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment Cancer Research. 70: 8695-8705. PMID 20864511 DOI: 10.1158/0008-5472.Can-10-2318 |
0.349 |
|
| 2010 |
Harikumar KB, Kunnumakkara AB, Ochi N, Tong Z, Deorukhkar A, Sung B, Kelland L, Jamieson S, Sutherland R, Raynham T, Charles M, Bagherzadeh A, Bagherazadeh A, Foxton C, Boakes A, et al. A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo. Molecular Cancer Therapeutics. 9: 1136-46. PMID 20442301 DOI: 10.1158/1535-7163.Mct-09-1145 |
0.305 |
|
| 2009 |
Matsuo Y, Raimondo M, Woodward TA, Wallace MB, Gill KR, Tong Z, Burdick MD, Yang Z, Strieter RM, Hoffman RM, Guha S. CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer. International Journal of Cancer. Journal International Du Cancer. 125: 1027-37. PMID 19431209 DOI: 10.1002/Ijc.24383 |
0.434 |
|
| 2009 |
Matsuo Y, Ochi N, Sawai H, Yasuda A, Takahashi H, Funahashi H, Takeyama H, Tong Z, Guha S. CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer. International Journal of Cancer. 124: 853-61. PMID 19035451 DOI: 10.1002/Ijc.24040 |
0.365 |
|
| 2008 |
Tong Z, Kunnumakkara AB, Wang H, Matsuo Y, Diagaradjane P, Harikumar KB, Ramachandran V, Sung B, Chakraborty A, Bresalier RS, Logsdon C, Aggarwal BB, Krishnan S, Guha S. Neutrophil gelatinase-associated lipocalin: A novel suppressor of invasion and angiogenesis in pancreatic cancer Cancer Research. 68: 6100-6108. PMID 18676832 DOI: 10.1158/0008-5472.Can-08-0540 |
0.471 |
|
| 2006 |
Tong Z, Wu X, Chen CS, Kehrer JP. Cytotoxicity of a non-cyclooxygenase-2 inhibitory derivative of celecoxib in non-small-cell lung cancer A549 cells. Lung Cancer (Amsterdam, Netherlands). 52: 117-24. PMID 16497409 DOI: 10.1016/J.Lungcan.2005.12.003 |
0.408 |
|
| 2005 |
Tong Z, Wu X, Ovcharenko D, Zhu J, Chen CS, Kehrer JP. Neutrophil gelatinase-associated lipocalin as a survival factor. The Biochemical Journal. 391: 441-8. PMID 16060857 DOI: 10.1042/Bj20051020 |
0.53 |
|
| 2003 |
Tong Z, Singh G, Valerie K, Rainbow AJ. Activation of the stress-activated JNK and p38 MAP kinases in human cells by Photofrin-mediated photodynamic therapy. Journal of Photochemistry and Photobiology. B, Biology. 71: 77-85. PMID 14705642 DOI: 10.1016/J.Jphotobiol.2003.08.001 |
0.609 |
|
| 2003 |
Tong Z, Wu X, Kehrer JP. Increased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886. The Biochemical Journal. 372: 203-10. PMID 12614196 DOI: 10.1042/Bj20021696 |
0.4 |
|
| 2002 |
Tong Z, Singh G, Rainbow AJ. Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy. Cancer Research. 62: 5528-35. PMID 12359764 |
0.582 |
|
| 2001 |
Tong Z, Singh G, Rainbow AJ. Extreme dark cytotoxicity of Nile Blue A in normal human fibroblasts. Photochemistry and Photobiology. 74: 707-11. PMID 11723799 DOI: 10.1562/0031-8655(2001)074<0707:Edconb>2.0.Co;2 |
0.575 |
|
| 2000 |
Tong Z, Singh G, Rainbow AJ. The role of the p53 tumor suppressor in the response of human cells to photofrin-mediated photodynamic therapy. Photochemistry and Photobiology. 71: 201-10. PMID 10687395 DOI: 10.1562/0031-8655(2000)071<0201:Trotpt>2.0.Co;2 |
0.631 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2019 |
Veeranki OL, Tong Z, Dokey R, Mejia A, Zhang J, Qiao Y, Singh PK, Katkhuda R, Mino B, Tailor R, Canales JR, Bassett R, Ajani J, Wu JY, Kopetz S, et al. Targeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinoma. Oncotarget. 10: 4703-4718. PMID 31384397 DOI: 10.18632/oncotarget.27095 |
0.265 |
|
| 2019 |
Veeranki OL, Tong Z, Mejia A, Verma A, Katkhuda R, Bassett R, Kim TB, Wang J, Lang W, Mino B, Solis L, Kingsley C, Norton W, Tailor R, Wu JY, et al. A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries. Disease Models & Mechanisms. PMID 31732509 DOI: 10.1242/dmm.041004 |
0.263 |
|
| 2016 |
Zhang H, Wang L, Guo C, Tong Z, Liu Y, Meng X, Feng H, Chen Y. Response of mouse thymic cells to radiation after transfusion of mesenchymal stem cells. Medicine. 95: e5295. PMID 28002319 DOI: 10.1097/MD.0000000000005295 |
0.25 |
|
| 2019 |
Tong Z, Mejia A, Veeranki O, Verma A, Correa AM, Dokey R, Patel V, Solis LM, Mino B, Kathkuda R, Rodriguez-Canales J, Lin SH, Krishnan S, Kopetz S, Blum M, et al. Targeting CDK9 and MCL-1 by a new CDK9/p-TEFb inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma. Therapeutic Advances in Medical Oncology. 11: 1758835919864850. PMID 31384313 DOI: 10.1177/1758835919864850 |
0.208 |
|
| 2011 |
Wang W, Lin J, Guha S, Tong Z, Cameron AG, Zhang F, Qiu X, Zou C, Gao X, Mawad ME, Ke S. Target-specific agents imaging ectopic and orthotopic human pancreatic cancer xenografts. Pancreas. 40: 689-94. PMID 21654540 DOI: 10.1097/Mpa.0B013E31821F6B14 |
0.193 |
|
| 2016 |
Tong Z, Shen H, Yang D, Zhang F, Bai Y, Li Q, Shi J, Zhang H, Zhu B. Genetic Variations in the Promoter of the APE1 Gene Are Associated with DMF-Induced Abnormal Liver Function: A Case-Control Study in a Chinese Population. International Journal of Environmental Research and Public Health. 13. PMID 27463724 DOI: 10.3390/ijerph13080752 |
0.087 |
|
| 2023 |
Khanduri I, Maki H, Verma A, Katkhuda R, Anandappa G, Pandurengan R, Zhang S, Mejia A, Tong Z, Soto LMS, Jadhav A, Wistuba II, Kopetz S, Parra ER, Vauthey JN, et al. New Insights into Macrophage Polarization and its Prognostic Role in Patients with Colorectal Cancer Liver Metastasis. Research Square. PMID 37886575 DOI: 10.21203/rs.3.rs-3439308/v1 |
0.075 |
|
| 2014 |
Tong Z, Shi J, Zhu X, Zhu B. [Death after exposure to dimethylformamide: a case report]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi = Zhonghua Laodong Weisheng Zhiyebing Zazhi = Chinese Journal of Industrial Hygiene and Occupational Diseases. 32: 285-6. PMID 24754947 |
0.073 |
|
| 2015 |
Shen H, Dou J, Han L, Bai Y, Li Q, Hong Z, Shi J, Zhang H, Zhang F, Du C, Tong Z, Zhu B. Genetic variation in APE1 gene promoter is associated with noise-induced hearing loss in a Chinese population. International Archives of Occupational and Environmental Health. PMID 26507517 DOI: 10.1007/s00420-015-1100-8 |
0.046 |
|
| 2020 |
Morris JS, Luthra R, Liu Y, Duose DY, Lee W, Reddy NG, Windham J, Chen H, Tong Z, Zhang B, Wei W, Ganiraju M, Broom BM, Alvarez HA, Mejia A, et al. Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33109741 DOI: 10.1158/1078-0432.CCR-20-2403 |
0.016 |
|
| Hide low-probability matches. |